Catholic University of Sacred Heart, Rome
Also known as: Allergy Department, Catholic University of the Sacred Heart | Andrea Giaccari | Catholic University | Catholic University, Italy | Catholic University of Rome | Catholic University of sacred Heart | Catholic University of Sacred Heart | Catholic University of the Sacred Heart | Catholic University of the Sacred Heart - Rome | Catholic University of the Sacred Heart, Rome | Catholic University Rome | Chatolic University of Sacred Heart, Roma | Department cardiovascular diseases A. Gemelli Polyclinic , University Sacred Heart in Rome | Department of Internal Medicine, Catholic University of Rome | Division of Oncologic Gynecology, Fondazione Policlinico Gemelli | Fondazione di Ricerca e Cura Giovanni Paolo II , Campobasso , Italy | Fondazione Policlinico A. Gemelli | Istituto di Reumatologia Complesso Integrato Columbus - Policlinico Gemelli Roma | Luca Cardone | Policlinico Universitario A.Gemelli | Policlinico Universitario A. Gemelli | Policlinico Universitario A. Gemelli - Rome - Italy | Policlinico Universitario Agostino Gemelli | The Catholic University of the Sacred Heart | University Sacred Heart in Rome
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2002Last known activity
Jun 1, 2025
Timeline
1920s
- Dec 7, 1921
Catholic University of Sacred Heart, Rome— Founded
Drugs by trial phase (107 distinct, 91 trials)
Phase 4 (27 own, 0 via acquisition)
Phase 3 (29 own, 0 via acquisition)
Phase 2 (28 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (18 own, 0 via acquisition)
Indications
Studied for
- Acid-Base Imbalance
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Acute Kidney Injury
- Acute Lung Injury
- Alcoholism
- Amyotrophic Lateral Sclerosis
- Anterior Wall Myocardial Infarction
- Arteriosclerosis
- Asthma
- Atrial Fibrillation
- Back Pain
- Breast Neoplasms
- Carcinoma, Ovarian Epithelial
- Cardiovascular Diseases
- Cataract
- Cholecystolithiasis
- Cholelithiasis
- Clostridium Infections
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Communicable Diseases
- Confusion
- Constipation
- Coronary Artery Disease
- Coronary Disease
- Diverticular Diseases
- Diverticulum
- Endometrial Neoplasms
- Endometriosis
- Enterocolitis, Pseudomembranous
- Fibrosis
- Gallstones
- Genetic Diseases, Inborn
- Glaucoma
- Glaucoma, Open-Angle
- Heart Failure
- Helicobacter Infections
- HIV Infections
- Homocystinuria
- Hyperplasia
- Hypersensitivity
- Hypersensitivity, Immediate
- Hypertension
- Infarction
- Infections
- Infertility
- Infertility, Female
- Insulin Resistance
- Liver Cirrhosis
- Liver Cirrhosis, Alcoholic
- Low Back Pain
- Lung Injury
- Macular Degeneration
- Motor Neuron Disease
- Mucositis
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Myocardial Infarction
- Myocardial Ischemia
- Myocardial Stunning
- Neoplasm Metastasis
- Neoplasms
- Neuroblastoma
- Ocular Hypertension
- Ovarian Neoplasms
- Overweight
- Pharyngitis
- Polycystic Ovary Syndrome
- Prostatic Hyperplasia
- Rectal Neoplasms
- Renal Insufficiency
- Respiratory Distress Syndrome
- Retinal Degeneration
- Sclerosis
- Status Epilepticus
- Stomatitis
- Substance Withdrawal Syndrome
- Syndrome
- Thromboembolism
- Ulcer
Recent trials (50)
- NCT06992453Lead sponsorN/AJun 1, 2025
- NCT06992453Sponsor investigatorN/AJun 1, 2025
- NCT05733572Lead sponsorPhase 2Jun 12, 2023
- NCT05733572Sponsor investigatorPhase 2Jun 12, 2023
- NCT05360264CollaboratorPhase 2Jan 15, 2022
- NCT05218564CollaboratorN/AFeb 19, 2020
- NCT04155554CollaboratorPhase 3Dec 31, 2019
- NCT03766321CollaboratorN/AFeb 28, 2019
- NCT03693781CollaboratorPhase 2Jan 30, 2019
- NCT03705403CollaboratorPhase 2Dec 1, 2018
- NCT04040712Lead sponsorN/AJul 1, 2018
- NCT04040712Reponsible party - principal investigatorN/AJul 1, 2018
- NCT03447847Lead sponsorN/AMay 1, 2018
- NCT03447847Reponsible party - principal investigatorN/AMay 1, 2018
- NCT03656328Lead sponsorN/AApr 1, 2018
Details
- Founded
- Rome, IT Dec 7, 1921
- Last known activity
- Jun 1, 2025